Results 221 to 230 of about 32,290,400 (291)
Enhancing medical record management: effective implementation of operational standards at Wallaga University Comprehensive Specialized Hospital, 2025. [PDF]
Bayisa G +12 more
europepmc +1 more source
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand +5 more
wiley +1 more source
Improving the Assessment and Management of Constipation in Elderly Inpatients: A Quality Improvement Project in a Geriatric Ward. [PDF]
Yirdaw BG, Shaikh HA, Adekiya V.
europepmc +1 more source
ABSTRACT Objective Early risk stratification may support clinical decision‐making in spontaneous intracerebral hemorrhage (ICH). We aimed to develop and internally validate HAGIV, a score integrating frequency of imaging markers (FIM), a time‐adjusted non‐contrast computed tomography (CT) metric of hematoma expansion, with established predictors for 90‐
Lei Song +10 more
wiley +1 more source
Collective interests, health research ethics and data governance for Indigenous Sámi populations. [PDF]
Siri SRA, Mienna CS, Axelsson P.
europepmc +1 more source
ABSTRACT Background Factors associated with relapse course and disability in myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) remain incompletely understood. Objectives To identify clinical and modifiable factors associated with relapse and disability in MOGAD. Methods In this ambispective multicentre cohort study using data from
Yingtao Wang +23 more
wiley +1 more source
Deliberative Lab Communication and the Practice of Ethical Science. [PDF]
Plemmons DK, Esterling KM, Gunsalus CK.
europepmc +1 more source
Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use
ABSTRACT Background Primary mitochondrial disease is a group of genetic disorders caused by pathogenic variants in nuclear or mitochondrial DNA, often resulting in progressive neurodegeneration and cognitive decline. Current management is primarily supportive, though recent research offers hope for disease‐modifying treatments in the future.
Oksana Pogoryelova +9 more
wiley +1 more source
Mapping policy gaps and governance challenges in Kenya's hand hygiene environment: a health policy triangle analysis. [PDF]
Njeri N, Moitui JN, Mberu B, Simiyu SN.
europepmc +1 more source

